Do you have Questions? Call us today: 855-770-4002
John H. Abeles, MD, Ph.D is a USA based venture investor, director of companies, consultant, entrepreneur and philanthropist.
Since March 1992, Dr. Abeles has been the Founder, Sole Investor and General Partner of Northlea Partners Ltd., a venture and private capital, family partnership headquartered in Boca Raton, Florida, which has had numerous investments, both active and passive, mainly in the health care arena but also in other fields.
Henry Schein is the largest distributor of health care products and services to medical, dental and veterinary office-based practitioners in the world. Revenues in 2010 were $7.5 billion and its dental division serves 87% of the estimated 143,000 U.S. and Canadian office-based dental practices.
Brand Rules provides brand and marketing consulting to C-level executives in a variety of industries including automotive and high technology. Mr. Hughes was the founding CEO of Land Rover of North America and served as the CEO of Mazda of North America. He currently serves on several boards including Duke Integrative Medicine at Duke University.
Dr. Mourad is a renowned expert in the field of therapeutic ultrasound in both medical and dental applications. He holds numerous patents, including several for the ultrasound toothbrush and drug delivery technologies. Dr. Mourad is the Principal Physicist at the Center for Industrials and Medical Ultrasound at the University of Washington, where he has been on the faculty since 1988. He also serves as an Associate Professor in the Neurological Surgery, Pediatric Dentistry and Bioengineering departments. Dr. Mourad is a founder of PhysioSonics, a medical device development company whose investors include Medtronic and Johnson & Johnson.
Dr. Okie is currently in practice and the Medical Director of Family Care Partners in Jacksonville, Florida, a multisite primary care practice with over 100,000 patients. He graduated from Jefferson Medical College and completed a residency in pediatrics and a fellowship in allergy and immunology. He entered private practice in 1973 and operated a managed care company with over 1,000,000 capitated with HMOs around the country for allergy services.
Dr. Ritsco has published extensively in several scientific journals and has lectured and taught dentists internationally on many facets of advanced dentistry. He serves on the adjunct faculty at the University of Texas Health Science Center at Houston and serves on the Dean's faculty at the University of Maryland Dental School in Baltimore.
Mr. Harris was appointed President and Chief Executive Officer of Dental Resource Systems (DRS) in May 2011.
He previously served as Chief Technology Officer and General Manager of the Government and Commercial Services division of Communications Services for the Deaf Video Relay Service (CSDVRS), the second largest provider of telecommunications in the $750MM video relay service industry.
Dr. Montgomery has been committed to excellent patient care since graduating from Oregon Health Sciences University in 1980. His experience in all aspects of dental care has been enhanced by extensive work in continuing dental education. This background has built a strong commitment to comprehensive health, grounded in beautiful smiles, excellent chewing function, and a health biological focus
Vicki graduated from Brigham Young University with a Bachelors of Family and Home Sciences, and began her career of helping people as an office manager for both dental and medical practices in 1979. She continued to provide her unique level of customer care as the Customer Service Manager at Utah Valley Dental Lab until joining DRS in 2009.
Scott joined DRS in 2009 after technical leadership and management positions within Henry Schein's software group, including Dentrix, Easy Dental and Vipersoft/Clarity. Henry Schein is the largest dental products distributor and services provider in the world. Mr. Peterson is responsible for managing the technology services and support organization for TruDenta practices and DRS.
Since 1980, Dr. Abeles has also been President of MedVest, Inc., a business and financial consulting firm. He has been instrumental in helping promulgate many early stage medical and other companies, some are still private and several have emerged into the public arena.
He has been a Managing Member of ProMed Capital LLC, a New York investment group promulgating Israeli medical venture companies and investments. ProMed has initiated three major Israeli investments: Althera (local, alpha-particle brachytherapy treatment of solid tumors); Endogun (surgical system for gynecology and urology surgery); HDH (stitchless vascular anastomosis system).
Regarding the public companies on the Boards of which he is currently, he has been a director of Oryx Technology since its organization in July 1993 and served as Chairman of its Board of Directors from October 1993 until April 1997. Dr. Abeles served on the Board of Directors of I-Flow Corporation; a company that manufactures infusion devices (recently acquired by KimberlyClark); DUSA Pharmaceuticals, Inc. a publicly traded company, which is developing dermatology and photodynamic therapy products; Oryx Technology, a public software company; Combimatrix, a diagnostic company; and CytoCore, Inc, which is researching medical diagnostic equipment.
Past public companies he has helped to promulgate include Encore Medical (an orthopedics/physiatry company acquired by Blackstone Capital; Newport Pharmaceuticals acquired by Merck; Imre Corporation acquired by Fresenius; ProCyte a biotech company acquired by PhotoMeex.
Regarding private companies, he is a Director of Alison Raffaele Cosmetics; BioStar (breast cancer science); Unimedica (medical education); ContraFect (anti-infective immunology): Etubics Corp (new navvine and DNA vectors); and MediSync BioSciences, a CRO (contract research organization) roll-up concern. He was an early promulgator of InSound Corp, an advanced hearing aid company, recently acquired privately by Sonova; and was a Director of Textronics, an intelligent textiles company, acquired by Adidas.
Dr. Abeles serves as an Advisory Board Member of the College of Chemistry, University of California, Berkeley, and has been on the Advisory Board of the Higuchi BioSciences Institute at the University of Kansas. He is a Fellow of the Royal Society of Medicine, London.
He is a Director of the International Opera Alliance, New York and a member of the Players Club, New York, which is given to the promulgation of the dramatic and performance arts. He is also on the board of the New Group, a theater organization in New York. Dr. Abeles is the President of Dalyda Finance Corp, which supports and invests in promising performing artists, artists and projects. Northlea and also Dalyda make investments in theater and film.
He is an avid football (Niners) and baseball (Athletics) fan, and a fitness enthusiast.
He has a diploma in music from the Royal Schools of Music (piano and violin). He thanks the fates for good books and worthy movies (a strong passion) which have illuminated his life. He is married thirty-three years to Mimi, a classical singer and a classic beauty. They have three grown children, all successful performing artists in drama and music.
back to bio overview
In the Orthodontic Community:
After completing my training, I served as chief of orthodontics at the Royal Air Force in Upper Heyford, England, for four years. I then became a member of the craniofacial reconstructive team and taught in the maxillofacial training program during my assignment at California's David Grant Medical Center at Travis Air Force Base. Then, during the Persian Gulf War, I served as chief of orthodontics at the Torrejon Air Force Base in Madrid, Spain. My final military assignment was at Davis-Montham Air Force Base in Tucson, Arizona, where I served as chief of orthodontics before retiring from the U.S. Air Force.
Outside the Office:
My wife, Mary Lynn, and I have been happily married since 1973. We have four children: Bryan, Laurie, Chase, and Scott. In addition to working as an orthodontist, I pursued theological training at the Southwestern Theological Seminary and received my Master's of Divinity degree in Evangelism and Missions. As an ordained Southern Baptist minister, I am currently involved in assisting the poor and homeless in my community.
back to bio overview
Education and Continuing Education:
As a member of many professional associations in the field of orthodontics, I have the opportunity to learn about new advancements in treatments and appliances to give my patients the best care available.
back to bio overview
I regularly attend continuing education classes and participate in different seminars held in Texas and throughout the United States. Through research, the orthodontic profession has grown as new materials and treatment modalities are developed that improve the quality of care. I believe it’s my duty as a clinician to be familiar with these advances.
Outside the Office
I am blessed to be part of a loving family and look forward to visiting my wonderful parents in Massachusetts and my sister’s family in Houston as often as I can. When I am not visiting family, I like planning trips around the world to learn about different cultures and their histories.
back to bio overview
TAt CSDVRS, he launched several successful new products and dramatically grew revenues over a 36-month period. Prior to CSDVRS, Mr. Harris was CEO and CTO of CHANGE VISEON TO VSNI Inc. Viseon, Inc., developing a fully integrated multi-media communication device for broadband carriers and large cable companies. From 1986 until 1998, Mr. Harris was founder and CEO of CompuNet Support Systems, Inc. a systems integrator, specializing in technology integration for professional service firms, including medical and dental practices. He has authored or co-authored several patents related to broadband communications technologies.
back to bio overview
Dr. Montgomery is well known for his mastery of skills in the areas of Invisalign orthodontics, smile enhancement and veneer, reconstruction and restoration of worn and damaged teeth, and in controlling tooth grinding, dentomandibular sensorimotor dysfunction, and head/face pain. His greatest talents are in the area of comprehensive diagnosis of complex problems.
Dr. Montgomery currently partners with Aesthetic Masters and UNLV, in live patient hands-on curricula for post-graduate clinical studies. He also is Chief Dental Officer at Dental Resource Systems, as well as, an educator with Pride Institute in the area of Clinical Management. Dr. Montgomery was on the faculty of AlignTech Institute, training dentists in the Invisalign system. He presents continuing education courses, affiliated with the Aesthetic Masters Group, in the areas of occlusion and full mouth reconstruction.
1976 BS Zoology from Oregon State University with honors
1980 DMD from Oregon Health Sciences University
1980-1991 Private Practice General Dentistry, Keizer Oregon
1991-2011 Private Practice General Dentistry, Oregon
2010-present Chief Dental Officer of Dental Resource Systems
1982 Normandie Study Group on TMJ (mini-internship)
1988 Lee Institute Bio-Aesthetic continuum on occlusion and full mouth reconstruction
1997 OHSU mini-residency on implant placement and restoration
2007 Fellowship in Academy of Comprehensive Aesthetics
Continuing Education Presentations:
back to bio overview
Perhaps her most important and challenging achievement has been as the mom of six wonderful children. You must see the video testimonials to believe the patient amazement, and you must meet Vicki to fully understand the term "customer love."
back to bio overview
Patients search online for relief from the symptoms of force imbalance 297% more often than for all dental services combined!
TruDenta will add $100,000 to your practice in the first year. Some add more than $1,000,000 per year from TruDenta alone.
Elements of TruDenta are being used by orthodontists in every case start, adult and pedi, conventional braces and Invisalign.
In many cases, only dental professionals can help the estimated 80 million Americans suffering from the painful symptoms caused by improper dental forces, called dentomandibular sensorimotor dysfunction (DMSD).
READ MORE "...it is imperative to include the training for orofacial pain, particularly those from temporomandibular joint and musculoligamentous tissues.” JADA Cover Story, 10/2015, Vol. 146, Issue 10, Pg. 721-728
20% of your existing patients suffer from DMSD, as do 20% of all Americans. Your team members quickly assess patients for "red flags" (which indicate DMSD), utilizing TruDenta's patented technologies.
The National Institutes of Health estimate that over 80 million Americans suffer from one or more of the symptoms of DMSD, including:
• Chronic Headache
TruDenta uses digital force measurement technology, powered by Tekscan®, for evaluating the amount of bite force that is present during closure, at closure, and while chewing. The technology is so advanced that it actually calculates the bite force and motion on a tooth-by-tooth basis. This digital exam literally shows a movie of the bite force in action revealing abnormal forces in the nerves, muscles and ligaments that are often the cause of symptoms.
Bite balance is also calculated to identify potential issues within the overall chewing system. READ MORE
A normal opening for an adult is 53 mm to 57 mm. Limited or restricted range of motion (less than 40 mm) is a reduction in an individual’s ability for normal range of movement. Along with opening movement, an individual should be able to slide their jaw to the left and to the right at least 25 percent of their total mouth opening in a symmetrical fashion.
When restricted movement exists, an imbalance in the system is present, and breakdown of the system is likely to occur. READ MORE
The TruDentaROM is a system of hardware and software that digitally measures cervical range of motion (ROM) impairment based upon AMA guidelines. This directly affects the proprioceptive feedback system of the dental occlusion, TMJ, and the muscles of mastication.
ROM impairment is another “red flag” which assists doctors in accurately diagnosing symptoms that are often dental force related. This data enhances medical insurance collections and the collaboration with referring medical doctors. READ MORE
A typical case requires less than one hour of doctor time in the diagnosis and minor occlusal adjustments during the rehabilitation period.
Treatments are performed by a trained team member once per week, in less than one hour. The most severe cases require 12 treatments. Therapies are spa-like, non-invasive and require no drugs or needles. Most patients report dramatic results after the very fist treatment. Note: The majority of patients utilize an orthotic only during the treatment period, up to a maximum of 12 weeks. READ MORE
The goal of therapeutic ultrasound treatment is to return circulation to sore, strained muscles through increased blood flow and heat. Another goal is to break up scar tissue and deep adhesions through sound waves.
Therapeutic exposure to ultrasound reduces trigger point sensitivity and has been indicated as a useful clinical tool for managing myofacial pain. Additionally, ultrasound also has been shown to evoke antinociceptive effects on trigger points. READ MORE
Sub-threshold microcurrent stimula¬tion reduces muscle spasm and referral pain through low electrical signal. It also decreases lactic acid build-up and encourages healthy nerve stimulation. In particular, microcurrent electrotherapy has been shown to help increase mouth opening significantly.
• Reduces muscle spasm and referral pain through low electrical signal
• Decreases lactic acid build-up
• Encourages healthy nerve stimulation
• Increases mouth opening significantly
Low level laser/light therapy is one of the most widely used treatments in sports medicine to provide pain relief and rehabilitation of injuries. Over 200 randomized clinical trials have been published on low level laser therapy, half of which are on pain.
Low level laser/light therapy decreases pain and inflammation, accelerates healing of muscle and joint tissue 25 to 35 percent faster than without treatment, and reconnects neurological pathways of nerves to the brain stem, thereby inhibiting pain. READ MORE